This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Oncotherapy Science, Incorporated, Tokushima University. Active years: 2021-2026.
Company Filing History:
2 out of 150 
1 out of 42 
Years Active: 2021-2026
Title: Tetsuro Yoshimaru: Innovator in Peptide Derivatives
Introduction
Tetsuro Yoshimaru is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide derivatives. His work focuses on innovative solutions for cancer therapy, showcasing his commitment to advancing medical science.
Latest Patents
Tetsuro Yoshimaru holds a patent for a peptide derivative and pharmaceutical composition containing the same. The patent describes peptides that incorporate portions of a dominant-negative peptide of BIG3, which inhibits the interaction between BIG3 and PHB2. These peptides exhibit excellent cell growth inhibiting activity, which lasts longer compared to single-stapled peptides. This characteristic makes them particularly suitable for clinical applications in cancer therapy.
Career Highlights
Throughout his career, Tetsuro Yoshimaru has been associated with prestigious institutions such as Tokushima University and Oncotherapy Science, Incorporated. His work in these organizations has allowed him to explore and develop innovative therapeutic approaches.
Collaborations
Tetsuro has collaborated with notable colleagues, including Toyomasa Katagiri and Takashi Miyamoto. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Tetsuro Yoshimaru's contributions to peptide derivatives and cancer therapy highlight his role as an influential inventor in the pharmaceutical field. His innovative work continues to pave the way for new therapeutic options in the fight against cancer.